Primary sclerosing cholangitis is a currently incurable liver disorder, primarily affecting younger adults aged between 30 and 40. A European multi-center Phase II study has now shown that this disease could be potentially be cured using a synthetically manufactured bile acid (active agent: nor-ursodeoxycholic acid/nor-urso).